Lista de obras -

Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions

artículo científico publicado en 2002

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

article

Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection

artículo científico publicado en 2005

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients

artículo científico publicado en 2012

Epistasis among deleterious mutations in the HIV-1 protease

artículo científico publicado en 2009

Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness

artículo científico publicado en 2012

Genetic and catalytic efficiency structure of an HCV protease quasispecies

artículo científico publicado en 2007

Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease

artículo científico publicado en 2004

Gut Microbiota Linked to Sexual Preference and HIV Infection.

artículo científico publicado en 2016

HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions

artículo científico publicado en 2006

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

artículo científico publicado en 2012

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients

artículo científico publicado en 2014

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

artículo científico publicado en 2010

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation

artículo científico publicado en 2002

Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy

artículo científico publicado en 2004

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

article

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.

artículo científico publicado en 2018

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication

article

Lista de obras de

Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients

Epistasis among deleterious mutations in the HIV-1 protease

Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness

Genetic and catalytic efficiency structure of an HCV protease quasispecies

Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease

Gut Microbiota Linked to Sexual Preference and HIV Infection.

HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients

IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation

Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication